While the outbreak is over, the City of Victoria and shelter providers are taking steps to prevent future illnesses after an individual showed signs of shigella earlier this week.

BROOME COUNTY, N.Y. (WBNG) — The Broome County Health Department has observed an increase in medical cases for a bacterial illness that can result in severe stomach complications for roughly a week, ...

Water is an essential resource for human life, yet safe water for domestic use remains scarce, especially for some communities in low- and middle-income countries. Approximately 785 million people ...

The family of a woman who died after falling ill with a stomach bug at a five-star resort in Cape Verde has accused package holiday firm Tui of a "catalogue of errors" in the days before her death.

Since last August, the Broome County Health Department has reported an abnormally large increase in cases of shigellosis, an intestinal infection from the Shigella ...

Anyone who has felt queasy, been sick, or had a unsettled tummy has likely tried ginger or been advised to do so. Ginger has been trusted for centuries as a gentle and reliable solution to many a ...

Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company today released half-year financial results and separately a presentation outlining its ...

In today’s interconnected world, the spread of pathogenic microorganisms poses a significant challenge to global public health, economic stability, and ...

Local volunteers have created a humanitarian project called “Humans of ICE” to share the stories of immigrants detained by ...

SAN CARLOS, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced financial results for the fourth quarter and full year ...

Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, announced today that it will report financial results for the fourth quarter and full year 2025 and provide a business update ...

Company Expects to Report Topline Data from OPUS-3 Trial and OPUS-2 Phase 3 Trial Evaluating Concomitant Administration of VAX-31 and a Seasonal Influenza Vaccine in First Half of 2027 OPUS-1, VAX-31 ...